EUVIMEDOpdag EUVIMED
Fallbericht

The application of leukocyte‐ and platelet‐rich fibrin (L‐PRF) in maxillary sinus augmentation

Charles A Powell, Alicia Casarez-Quintana, Jacob Zellner, Omar Al-Bayati, Kerri Font

Clinical Advances in Periodontics · 2022-12 · 12 (4) · 277-286

DOI: 10.1002/cap.10216 ↗

At a glance

Fallbericht in Clinical Advances in Periodontics, published online on 2022-10-25. Written by Charles A Powell and 4 co-authors. Institution: Department of Periodontics, UT Health San Antonio, San Antonio, Texas. Major MEDLINE topics: Platelet-Rich Fibrin, Sinus Floor Augmentation. Cited 8 times so far (Crossref); 13 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Since the introduction of sinus augmentation in the 1970s the procedure has been performed with or without biomaterials. Autologous blood products (ABPs) for use in sinus augmentation was first introduced in the 2000s, to aid potentially in bone and soft tissue healing.

Methods

Three different applications of leukocyte‐ and platelet‐rich fibrin (L‐PRF) in maxillary sinus augmentation are presented in this case series. In case 1, L‐PRF is used in bilateral sinus augmentation to support placement of implants to support a maxillary hybrid denture. Case 2 highlights the use of L‐PRF in a complication associate with Schneiderian membrane elevation. Case 3 provides histology taken at the time of implant placement 6 months following L‐PRF/xenograft sinus augmentation.

Results

All cases resulted in the successful placement of dental implants. In case 2, an osseodensification procedure was performed with freeze‐dried bone allograft, which provided an approximate 4 mm of additional vertical height for implant placement. Histology from case 3 at 6 months post sinus augmentation demonstrated the presence of new vital bone in contact with the xenograft.

Conclusion

To date, there is only a limited amount of evidence reporting on platelet‐rich fibrin (PRF) or L‐PRF use in maxillary sinus augmentation. Bone gain from either product has ranged from 3.2 to 11.8 mm, with the percentage of newly formed bone reported in case series as 33% ± 5%. Despite the lack of strong evidence, L‐PRF appears to have beneficial effects on bone regeneration when used in sinus augmentation.

Subjects

MeSH terms (MEDLINE)

Platelet-Rich FibrinSinus Floor AugmentationHumansMaxillary SinusBone TransplantationBone Regeneration

Author keywords

maxillary sinusosteogenesisplatelet-rich fibrin

Authors and institutions

  • Department of Periodontics, UT Health San Antonio, San Antonio, Texas.
  • Central Texas Periodontics, Austin, Texas.
  • Division of Periodontics, Department of Surgical Dentistry, University of Colorado School of Dental Medicine, Aurora, Colorado.

Cite

APA

Powell, C. A., Casarez-Quintana, A., Zellner, J., Al-Bayati, O., & Font, K. (2022). The application of leukocyte‐ and platelet‐rich fibrin (L‐PRF) in maxillary sinus augmentation. Clinical Advances in Periodontics, 12(4), 277-286. https://doi.org/10.1002/cap.10216

Vancouver

Powell CA, Casarez-Quintana A, Zellner J, Al-Bayati O, Font K. The application of leukocyte‐ and platelet‐rich fibrin (L‐PRF) in maxillary sinus augmentation. Clinical Advances in Periodontics. 2022;12(4):277-286. doi:10.1002/cap.10216

BibTeX
@article{Powell2022,
  author = {Powell, Charles A and Casarez-Quintana, Alicia and Zellner, Jacob and Al-Bayati, Omar and Font, Kerri},
  title = {The application of leukocyte‐ and platelet‐rich fibrin (L‐PRF) in maxillary sinus augmentation},
  journal = {Clinical Advances in Periodontics},
  year = {2022},
  volume = {12},
  number = {4},
  pages = {277--286},
  doi = {10.1002/cap.10216}
}
Start for free →